Bipartisan Drug Price Bills Paused Amid Criticism of Sanders (1)

Consensus on a package of bills intended to curb soaring drug prices is up in the air after a markup Tuesday disrupted by disagreements among senators over how to advance the legislation through the committee.

Bernie Sanders (I-Vt.), chair of the Senate health committee, postponed votes on four bills following criticism from Republicans over whether to consider amendments to the measures before receiving more information on their potential impacts. Members of both parties also questioned why the markup was being held before a May 10 hearing with chief executive officers of insulin manufacturing companies and pharmacy benefit managers.

After a ...